Vincent Bjorling
Hematology & Oncology · Scottsbluff, NENPI 1023027596
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 90.1% of the total across 66 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 21 manufacturers, the largest accounting for just 16.9% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $857 and has fallen 98.3% since, to $14 in 2023. That places this record below the midpoint for hematology & oncology clinicians in NE, where the typical reported total is $3,016.
Across 66 payments — averaging $17.11 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Merck$191
- Pharmacyclics LLC, An Abbvie Company$131
- Novartis$123
- Amgen$107
- E.r. Squibb & Sons, L.L.C.$87
- Tesaro, Inc.$51
- plus $439 from 15 others
What the payments were for
- Food & beverage$1,01790%
- Education$11210%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Merck | 12 | $191 |
| Pharmacyclics LLC, An Abbvie Company | 3 | $131 |
| Novartis | 9 | $123 |
| Amgen | 5 | $107 |
| E.r. Squibb & Sons, L.L.C. | 5 | $87 |
| Tesaro, Inc. | 2 | $51 |
| Genentech USA, Inc. | 3 | $49 |
| Rigel Pharmaceuticals, Inc. | 3 | $48 |
| Pfizer | 3 | $46 |
| Seagen Inc. | 3 | $46 |
| Lilly USA, LLC | 3 | $42 |
| Astellas Pharma US Inc | 2 | $31 |
| Bayer | 2 | $31 |
| Sanofi | 2 | $30 |
| Gilead | 2 | $24 |
| Johnson & Johnson | 2 | $24 |
| Tersera Therapeutics LLC | 1 | $16 |
| Array Biopharma Inc | 1 | $15 |
| Sanofi-aventis U.S. LLC | 1 | $14 |
| Boehringer Ingelheim | 1 | $14 |
| AstraZeneca | 1 | $12 |
How this compares
$1,129 in reported general payments places this provider in the 30th percentile of 73 hematology & oncology providers in Nebraska.
Other hematology & oncology in Scottsbluff
- Mojtaba AkhtariOmaha$1.8M
- Rabih FahedNorfolk$294K
- Luke NordquistOmaha$202K
- Apar Kishor GantiOmaha$138K
- Julie VoseOmaha$123K
- Peter SilbersteinOmaha$99K
- Krishna GundaboluOmaha$76K
- Vijaya BhattOmaha$58K
- Debora BrunoHastings$57K
- Pornchai JonglerthamHastings$48K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.